Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss

Nonalcoholic fatty liver disease (NAFLD) represents a rapidly growing cause of chronic liver disease in the United States and is associated with significant morbidity and mortality, including progression to liver cirrhosis and hepatocellular carcinoma. NAFLD comprises a spectrum of liver conditions, ranging from simple steatosis to steatosis with inflammation (steatohepatitis) and progressive fibrosis. Weight loss represents a first line therapeutic modality for the management of NAFLD. Herein, we review the evidence base for medical, surgical, and endoscopic approaches to weight loss and their potential impact on the natural history of NAFLD.

• Publication year

  2015

• Venue

  Journal of Clinical and Translational Hepatology

• Publication date

  2015-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.14218/JCTH.2015.00019PMID 26623270PMCID 4663205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• OC-016 Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, double-blinded, randomised, placebo-controlled phase ii trial

  2015cited by this paper
• G01 : Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, doubleblinded, randomised, placebo-controlled phase II trial

  2015cited by this paper
• Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective Study

  2015cited by this paper
• Nonalcoholic fatty liver disease: a systematic review.

  2015cited by this paper
• Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.

  2015cited by this paper
• Bariatric Surgery Improves Histological Features of Nonalcoholic Fatty Liver Disease and Liver Fibrosis

  2015cited by this paper
• Orthotopic liver transplantation in non-alcoholic fatty liver disease patients.

  2015cited by this paper
• Diets and nonalcoholic fatty liver disease: the good and the bad.

  2014cited by this paper
• The role of diet and nutritional intervention for the management of patients with NAFLD.

  2014cited by this paper
• Hepatic Pathology among Patients without Known Liver Disease Undergoing Bariatric Surgery: Observations and a Perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) Study

  2014cited by this paper
• Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance

  2014cited by this paper
• Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

  2013cited by this paper
• Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.

  2013cited by this paper
• Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.

  2013cited by this paper
• Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.

  2013influential reference
• Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?

  2013cited by this paper
• From NAFLD in clinical practice to answers from guidelines.

  2013influential reference
• Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

  2013cited by this paper
• Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study

  2013cited by this paper
• The Impact of Bariatric Surgery on Nonalcoholic Steatohepatitis

  2012cited by this paper
• Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.

  2012cited by this paper
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

  2012cited by this paper
• Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow‐up study

  2012cited by this paper
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

  2012cited by this paper
• Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

  2012cited by this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

  2012cited by this paper
• Weight reduction for non-alcoholic fatty liver disease.

  2011cited by this paper
• Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo‐controlled trial

  2011influential reference
• The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

  2011cited by this paper
• Current status of endoluminal bariatric procedures for primary and revision indications.

  2011cited by this paper
• Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.

  2011cited by this paper
• Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up

  2010cited by this paper
• Risk of all-cause and cardiovascular mortality in patients with chronic liver disease

  2010cited by this paper
• Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus

  2010cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

  2010cited by this paper
• Adherence is a multi-dimensional construct in the POUNDS LOST trial

  2010cited by this paper
• Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010cited by this paper
• Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

  2010cited by this paper
• Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes

  2010cited by this paper
• Bariatric surgery for non-alcoholic steatohepatitis in obese patients.

  2010cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

  2009cited by this paper
• Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.

  2009cited by this paper
• Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.

  2009cited by this paper
• Diet and Exercise Interventions Reduce Intrahepatic Fat Content and Improve Insulin Sensitivity in Obese Older Adults

  2009cited by this paper
• Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.

  2009cited by this paper
• Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

  2009cited by this paper
• Epidemiology and natural history of non-alcoholic steatohepatitis.

  2009cited by this paper
• Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma‐glutamyl transpeptidase levels

  2009cited by this paper
• Abortion ban leads to more maternal deaths in Nicaragua.

  2009cited by this paper
• Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

  2009cited by this paper
• Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.

  2008cited by this paper
• Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis

  2008cited by this paper
• Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.

  2008cited by this paper
• Incidence and natural course of fatty liver in the general population: The Dionysos study

  2007cited by this paper
• Change in Liver Size and Fat Content after Treatment with Optifast® Very Low Calorie Diet

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.

  2006cited by this paper
• The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

  2006cited by this paper
• Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).

  2005cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005cited by this paper
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

  2005influential reference
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

  2005cited by this paper
• Duodenal Switch Has No Detrimental Effects on Hepatic Function and Improves Hepatic Steatohepatitis after 6 Months

  2005influential reference
• Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

  2004cited by this paper
• The Importance of Routine Liver Biopsy in Diagnosing Nonalcoholic Steatohepatitis in Bariatric Patients

  2004cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

  2004cited by this paper
• Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.

  2004influential reference
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• The prevalence and etiology of elevated aminotransferase levels in the United States

  2003cited by this paper
• Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

  2003cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

  1997cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Effect of weight reduction on hepatic abnormalities in overweight patients.

  1990cited by this paper
• Nonalcoholic fatty liver disease.

  1986influential reference
• American Association for the Study of Liver Diseases

  1959cited by this paper

• Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease

  2024cites this paper
• Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice

  2024cites this paper
• New sesquiterpenes and viridin derivatives from Penicillium sp. Ameliorates NAFLD by regulating the PINK1/Parkin mitophagy pathway.

  2024cites this paper
• Dietary patterns and risk of non-alcoholic fatty liver disease in Korean adults: a prospective cohort study

  2023cites this paper
• Higher anthocyanin intake is associated with a lower risk of non-alcoholic fatty liver disease in the United States adult population

  2023cites this paper
• Current Advances in the Regulatory Effects of Bioactive Compounds from Dietary Resources on Nonalcoholic Fatty Liver Disease: Role of Autophagy.

  2023cites this paper
• Potentilla anserina L. attenuates oleic acid-induced steatosis in HepG2 cells and hyperlipidemia in high fat diet-induced obese mice

  2023cites this paper
• Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance

  2022cites this paper
• Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy

  2022cites this paper
• Dietary n-3 and n-6 fatty acid intakes and NAFLD: A cross-sectional study in the United States.

  2021cites this paper
• Dysregulation of components of the inflammasome machinery after bariatric surgery: novel targets for a chronic disease.

  2021cites this paper
• In vitro hepatic steatosis model based on gut–liver‐on‐a‐chip

  2021cites this paper
• Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge

  2020cites this paper
• Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis.

  2020cites this paper
• Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver

  2020cites this paper
• Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study.

  2020cites this paper
• Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study

  2020cites this paper
• Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences

  2020cites this paper
• Water Extract of Artemisia annua L. Exhibits Hepatoprotective Effects Through Improvement of Lipid Accumulation and Oxidative Stress-Induced Cytotoxicity

  2020cites this paper
• Hepatoprotective effect of polyphenols in rats with experimental thioacetamide-induced toxic liver pathology

  2019cites this paper
• Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors

  2019cites this paper
• A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study.

  2019cites this paper
• Gene chipset analysis in rats with non‐alcoholic fatty liver disease intervened by polyene phosphatidylcholine

  2018cites this paper
• Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

  2018cites this paper
• Comparative Study of Orange and its Main Bioactive Constituents as Remedy for Non-alcoholic Fatty Liver in Rats.

  2018cites this paper
• Rosmarinic acid attenuates hepatic steatosis by modulating ER stress and autophagy in oleic acid-induced HepG2 cells

  2018cites this paper
• Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials.

  2017cites this paper
• The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer

  2017cites this paper
• Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase.

  2017cites this paper
• The rising incidence of nonalcoholic fatty liver disease.

  2017cites this paper
• Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease

  2017cites this paper
• Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations

  2017cites this paper
• Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review

  2017cites this paper
• Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease

  2017cites this paper
• Non-alcoholic fatty liver disease and dyslipidemia: An update.

  2016cites this paper
• Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis

  2016cites this paper
• Nonalcoholic fatty liver disease as a multi-systemic disease.

  2016cites this paper
• The Role of Bariatric Surgery in the Management of Nonalcoholic Steatohepatitis.

  2016cites this paper
• Herbal medicines and nonalcoholic fatty liver disease.

  2016cites this paper
• Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials

  2016cites this paper
• Research on Anti-lipogenic Effect of Sobuncheong-eum on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease

  2016cites this paper